Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)

ClinicalTrials.gov ID: NCT02110901

Public ClinicalTrials.gov record NCT02110901. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 12:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Double-Blind, Placebo-Controlled Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease

Study identification

NCT ID
NCT02110901
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Proteon Therapeutics
Industry
Enrollment
349 participants

Conditions and interventions

Interventions

  • PRT-201 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2014
Primary completion
Nov 30, 2016
Completion
Nov 30, 2018
Last update posted
Jul 8, 2019

2014 – 2018

United States locations

U.S. sites
35
U.S. states
18
U.S. cities
32
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
AKDHC Medical Research Services , LLC Phoenix Arizona 85012
AKDHC Medical Research Services, LLc Tucson Arizona 85719
Alliance Research Center Laguna Hills California 92653
VA Medical Center Long Beach Long Beach California 90822
Keck University Hospital at USC Los Angeles California 90033
Kaiser Permanente Medical Center San Diego California 92120
California Institute of Renal Research San Diego California 92123
UCSF Division of Vascular & Endovascular Surgery San Francisco California 94143
Rush Medical Center Chicago Illinois 60612
Renal Care Associates Peoria Illinois 61603
Lutheran Hospital Network of Indiana Fort Wayne Indiana 46804
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
University of Louisville Louisville Kentucky 40202
Tulane University New Orleans Louisiana 70112
Louisiana State University Health Sciences Center Shreveport Louisiana 71130
Maine Medical Center Portland Maine 04102
University of Maryland Baltimore Maryland 21201
University of Maryland Shore Medical Center at Easton Easton Maryland 21601
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Brigham and Women's Hospital Boston Massachusetts 02482
University of Massachusetts Medical Center Worcester Massachusetts 01655
Mount Sinai Medical Center New York New York 10029
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599
Duke University Durham North Carolina 27710
W.G. Hefner VA Medical Center Salisbury North Carolina 28144
Wake Forest Winston-Salem North Carolina 27157
University of Cincinnati Medical Center Cincinnati Ohio 45267
University of Cincinnati Cincinnati Ohio 45267
Ohio State University Columbus Ohio 43210
The University of Oklahoma College of Medicine Tulsa Oklahoma 74104
Lehigh Valley Health Network Allentown Pennsylvania 18103
VA Pittsburg Healthcare System Pittsburgh Pennsylvania 15240
The Methodist Hospital Houston Texas 77030
Lake Washington Vascular Center Bellevue Washington 98004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02110901, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 8, 2019 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02110901 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →